Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma. Vilalta-Lacarra A, Aldaz A, Sala-Elarre P, Urrizola A, et al. Pancreatology 2023 Mar 14:S1424-3903(23)00065-0. doi: 10.1016/j.pan.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Vilalta-Lacarra A, Aldaz A, Sala-Elarre P, Urrizola A, et al. Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma. Pancreatology 2023 Mar 14:S1424-3903(23)00065-0. doi: 10.1016/j.pan.2023.
PMID: 37169668